|
|
||||||||
Differentially Augments Neocortical Neuronal Activity and Excitability
Department of Neurology, Neurobiological Laboratory, University of Rostock, Germany
Submitted 17 December 2003; accepted in final form 22 September 2004
The immunomodulatory cytokine interferon-
(IFN-
) is used in the treatment of autoimmune diseases such as multiple sclerosis. However, the effect of IFN-
on neuronal functions is currently unknown. Intracellular recordings were conducted on somatosensory neurons of neocortical layers 2/3 and 5 exposed to IFN-
. The excitability of neurons was increased by IFN-
(1010,000 U/ml) in two kinetically distinct, putatively independent manners. First IFN-
reversibly influenced the subthreshold membrane response by raising the membrane resistance RM 2.5-fold and the membrane time constant
1.7-fold dose-dependently. The effect required permanent exposure to IFN-
and was reduced in magnitude if the extracellular K+ was lowered. However, the membrane response to IFN-
in the subthreshold range was prevented by ZD7288 (a specific blocker of Ih) but not by Ni2+, carbachol, or bicuculline, pointing to a dependence on an intact Ih. Second, IFN-
enhanced the rate of action potential firing. This effect was observed to develop for >1 h when the cell was exposed to IFN-
for 5 min or >5 min and showed no reversibility (
210 min). Current-discharge (F-I) curves revealed a shift (prevented by bicuculline) as well as an increase in slope (prevented by carbachol and Ni2+). Layer specificity was not observed with any of the described effects. In conclusion, IFN-
influences the neuronal excitability in neocortical pyramidal neurons in vitro, especially under conditions of slightly increased extracellular K+. Our blocker experiments indicate that changes in various ionic conductances with different voltage dependencies cause different IFN-
influences on sub- and suprathreshold behavior, suggesting a more general intracellular process induced by IFN-
.
This article has been cited by other articles:
![]() |
L L. Mantia, D D'Amico, A Rigamonti, N Mascoli, G Bussone, and C Milanese Interferon treatment may trigger primary headaches in multiple sclerosis patients Multiple Sclerosis, August 1, 2006; 12(4): 476 - 480. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |